首页> 美国卫生研究院文献>Clinical Medicine Insights. Pathology >Diagnostic Value of TROP-2 and CK19 Expression in Papillary Thyroid Carcinoma in Both Surgical and Cytological Specimens
【2h】

Diagnostic Value of TROP-2 and CK19 Expression in Papillary Thyroid Carcinoma in Both Surgical and Cytological Specimens

机译:TROP-2和CK19在乳头状甲状腺癌中的诊断价值。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Papillary thyroid carcinoma (PTC) represents the most common primary malignant thyroid tumor and its diagnosis is dependent on the presence of classic nuclear features that are sometimes seen in some non-neoplastic and benign lesions. Several immunohistochemical markers are used individually or in combination to help in differentiation of PTC from mimickers. The aim of the current study was to assess the diagnostic value of TROP-2 and cytokeratin 19 (CK19) expression in differentiating PTC from other mimickers both singly and in combination. The current study was carried out on 77 surgical specimens (56 PTC and 21 non-neoplastic cases) and 12 cytological specimens (4 THY2, 6 THY4, and 2 THY5). TROP-2 was negative in 81% of non-neoplastic surgical specimens and in 100% of THY2 cytological specimens while it was positive in 71.4% of PTC surgical specimens and 100% of THY4/THY5 cytological specimens. Sensitivity and specificity of TROP-2 positive expression for diagnosis of PTC in surgical specimens reached 71% and 81%, respectively, while it reached 100% for both in cytological specimens. Cytokeratin 19 showed positive expression in 85.7% of non-neoplastic surgical specimens and in 92.9% of PTC surgical specimens. Cytokeratin 19 showed negative expression in 75% of Thy2 cases while it was positive in all studied Thy4 and Thy5 cases. Sensitivity and specificity of CK19 total estimated score for diagnosis of PTC in surgical specimens were 78.6% and 66.7%, respectively, while it reached 100% and 75% in cytological specimens. Positive TROP-2 and CK19 expression in PTC were associated with lymph node metastasis. TROP-2 is a specific rather than sensitive marker while CK19 is a sensitive rather than specific marker in differentiating PTC from other mimickers in surgical specimens. The diagnostic validity of both markers was superior in diagnosis of classic PTC compared with follicular variant PTC. TROP-2 is superior to CK19 in diagnosis of PTC in cytological specimens. Both TROP-2 and CK19 could be used preoperatively in adjunct to hematoxylin and eosin for more confident diagnosis of thyroid cytology and along with radiology as predictors of lymph node metastasis.
机译:甲状腺乳头状癌(PTC)是最常见的原发性甲状腺恶性肿瘤,其诊断取决于经典核特征的存在,这些特征有时在某些非肿瘤性和良性病变中可见。几种免疫组化标记物可单独使用或组合使用,以帮助区分PTC和模仿者。本研究的目的是评估TROP-2和细胞角蛋白19(CK19)表达在将PTC与其他mimickers单独或组合鉴别中的诊断价值。目前的研究是针对77例手术标本(56例PTC和21例非肿瘤病例)和12例细胞学标本(4例THY2、6例THY4和2例THY5)进行的。在81%的非肿瘤手术标本和100%的THY2细胞学标本中,TROP-2呈阴性,而在71.4%的PTC手术标本和100%的THY4 / THY5细胞学标本中呈阳性。在外科手术标本中诊断为PTC的TROP-2阳性表达的敏感性和特异性分别达到71%和81%,而在细胞学标本中两者均达到100%。细胞角蛋白19在非肿瘤外科手术标本中占85.7%,在PTC外科手术标本中占92.9%。细胞角蛋白19在Thy2病例的75%中呈阴性表达,而在所有研究过的Thy4和Thy5病例中呈阳性。 CK19在外科标本中诊断PTC的总估计分的敏感性和特异性分别为78.6%和66.7%,而在细胞学标本中则达到100%和75%。 PTC中TROP-2和CK19阳性表达与淋巴结转移有关。 TROP-2是特异性而非敏感标记,而CK19是区分PTC和手术标本中其他模仿者的敏感而不是特异性标记。与经典的PTC相比,两种标记物的诊断有效性均优于滤泡变体PTC。在细胞学标本中PTC的诊断中,TROP-2优于CK19。 TROP-2和CK19均可在术前同时使用苏木精和曙红,以更可靠地诊断甲状腺细胞学,并与放射学一起作为淋巴结转移的预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号